See product citations (22)
QUICK LINKS
AG 1024 selectively inhibits the IGF-1R (insulin-like growth factor 1 receptor). Human breast cancer cell studies report AG 1024 to induce apoptosis, inhibit cell proliferation, decrease bcl-2 and phospho-Akt1 expression, and elevate the expression levels of Bax, p53 and p21. Studies report AG 1024 to block tyrosine kinase activity and to have a lower IC50 for IGF-1 in comparison to insulin receptors. Other studies indicate that exposure of SHR cells to AG 1024 decreases Ang II-mediated NAD(P)H oxidase activation. AG 1024 is an inhibitor of insulin R.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
AG 1024, 1 mg | sc-205907 | 1 mg | $105.00 |